Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2025-12-27 @ 9:41 PM
Study NCT ID:
NCT01393795
Status:
COMPLETED
Last Update Posted:
2023-10-05
First Post:
2011-06-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients
Sponsor:
Imperial College London
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-08
Start Date Type:
None
Primary Completion Date:
2012-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-06-22
First Submit QC Date:
None
Study First Post Date:
2011-07-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-04
Last Update Post Date:
2023-10-05
Last Update Post Date Type:
ACTUAL